Skip to main content
Clinical Trials/NCT01503554
NCT01503554
Completed
N/A

Multidisciplinary Care Transition Intervention - Cardinal Health Grant

Rush University Medical Center1 site in 1 country100 target enrollmentApril 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Patient Admission
Sponsor
Rush University Medical Center
Enrollment
100
Locations
1
Primary Endpoint
30-day Same Hospital Readmission Rate
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

In an effort to improve care coordination and reduce hospital readmissions, Rush University Medical Center developed the Combined Social Worker and Pharmacist Program, which targets both the psychosocial and clinical risk factors that can lead to rehospitalization. This study will evaluate the impact of this program on 30-day same hospital readmission rates and total cost of care.

Detailed Description

If a patient is enrolled in the Combined Social Worker and Pharmacist Program their care will differ from usual care in a number of different ways. First, while the patient is in the hospital, an interdisciplinary group of providers will round on the patient on a regular basis. This interdisciplinary team will be composed of an attending physician, clinical pharmacist, nurse, case manager, and social worker, who will all evaluate the patient's needs from a variety of perspectives to ensure that the patient is prepared for discharge and self-manage post-discharge. During the patient's hospital stay, a clinical pharmacist will also conduct a detailed medication reconciliation of home medications, assess medication-related risks, and provide relevant education to patients participating in the program. After the patient is discharged from Rush University Medical Center, a Master's prepared social worker will then contact the patient and conduct an assessment from a psychosocial perspective to identify any unmet needs. Lastly, a clinical pharmacist will be available to patients enrolled in the Combined Social Worker and Pharmacist Program, should they have any medication-related questions post-discharge.

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
December 2011
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shannon Sims, MD

MD, PhD

Rush University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age \> 18
  • Planned discharge to home or home health
  • English-speaking
  • At least one of the following risk factors:
  • Use of high risk medication(s): Anti-coagulant therapy, dual ASA/plavix therapy, anticholinergic agent, digoxin, opioids, psychotropic medications, or erythrocyte stimulating factor
  • Clinical risk factor: Depression, fall risk, limited functional capacity, substance abuse, dementia
  • Psycho-social risk factor: high care giver burden, family conflict, limited health literacy, lives alone, significant patient stress, transportation concerns, health care scheduling concerns, inadequate emotional support.

Exclusion Criteria

  • Solid organ transplant
  • End-stage renal disease
  • Current chemotherapy or radiation therapy

Outcomes

Primary Outcomes

30-day Same Hospital Readmission Rate

Time Frame: 30 days following hospital discharge

Secondary Outcomes

  • Total Cost of Care(30 days following hospital discharge)

Study Sites (1)

Loading locations...

Similar Trials